RgenX-LENS is a multi-omics based biomarker and drug target discovery solution. It integrates genomics, transcriptomics, proteomics, metabolomics data with wet-lab validation and functional assays to deliver fully de-risked, decision-grade targets.

It enables faster, cost-effective biomarker discovery, drug repurposing, and vaccine development, significantly shortening the bench-to-bedside cycle thus bridging the gap from diagnosis to therapy. We identified a biomarker for Keratoconus that is at a pre-clinical stage.